NA Proactive news snapshot: Antibe Therapeutics, EuroLife Brands Inc, Constantine Metal Resources UPDATE …

Antibe Therapeutics Inc (CVE:ATE) is a ‘top pick’, according to Echelon Wealth Partners in a new research note hailing the firm’s lead pain management drug ATB-346. Data from Antibe’s Phase 2 study of ATB-346 is expected to be released in the coming weeks, with the fully-enrolled trial randomizing its last patient in February 2020. The research firm is maintaining a Speculative Buy rating and a price target of C$1.40 on the stock (current price: C$0.47). ATB-346 performed “exceedingly well” in an already-completed 246-patient Phase I/II gastro-duodenal ulceration rate trial, analysts Douglas Loe and Siew Ching Yeo wrote in a note. Constantine Metal Resources Ltd (CVE:CEM) (OTCQX:CNSNF) announced Friday that pursuant to the blanket relief granted by the Canadian Securities Administrators it did not file its interim financial statements for the quarter ended January 31, and the related management's discussion and analysis. The company expects to report results on or about April 8, and is afforded a postponement up to a maximum 45-day extension pursuant to blanket relief for all market participants granted by the Canadian Securities Administrators. In other nred. Ian Cunningham-Dunlop, vice-president of advanced projects, has resigned, effective March 31.  EuroLife Brands Inc (CSE:EURO) (OTCPINK:EURFF) is moving forward with a shareholder relief plan to reprice more than 59 million repurchase warrants in response to the market impact caused by the coronavirus (COVID-19). The company is repricing all warrants to $C0.05, including those with a previous exercise price of between C$0.05 and C$0.125 and an expiry date between May 4, 2020 and January 15, 2022.  The lower price increases the likelihood that warrant holders will be able to exercise their warrants prior to May 4. If all the warrants subject to the shareholder relief plan are exercised during that period, EuroLife expects to generate roughly C$2.96 million in proceeds. Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) has revealed it is temporarily suspending mining and processing at its Mexican mines to mitigate the spread of the coronavirus pandemic. In a stock market statement on Friday, the precious metals producer said activity at its Guanajuato Mine Complex (GMC) and the Topia mine would cease until April 30, in line with the directive of the Mexican government announced on March 31. Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF) reported that Love Hemp, a CBD supplier in the UK, and a subsidiary of World High Life Plc, in which the company is invested, has seen record monthly sales via its retail presence and e-commerce site. In an update on the early-stage investor's holdings, Codebase also told investors it is "actively pursuing" pharmaceutical opportunities that could have a positive impact on the current global coronavirus pandemic. CytoDyn Inc (OTCQB:CYDY), a late-stage biotechnology company, revealed Friday that it has filed a request with the US Food and Drug Administration (FDA), for a preliminary meeting to discuss positive new clinical data supporting its aim to win Breakthrough Therapy status for its lead drug leronlimab (PRO 140) in treating metastatic triple-negative breast cancer (mTNBC). The FDA had previously granted Fast Track designation to leronlimab for the treatment of metastatic triple-negative breast cancer. CytoDyn also said its president and chief executive officer Nader Pourhassan will appear on Fox Business Network on the “Making Money with Charles Payne” program on April 8. The program is on from 2:00 pm to 3:00 pm ET (11:00 am to 12 noon PT) and is also available via live streaming at https://www.foxbusiness.com/shows/making-money-with-charles-payne. He will discuss the treatment with leronlimab  of 10 severely ill coronavirus (COVID-19) patients at a New York hospital and express appreciation for a special hospital, physician, and medical team who treated them. In other news, Dr Pourhassan on Friday will reveal the name of a hospital and the physician in an interview that will air between 5-6:30 pm The interview is with CBS Seattle affiliate, KIRO 7. American Manganese Inc. (CVE:AMY) said an interview with its president & CEO Larry Reaugh will air on The RedChip Money Report television program on Sunday, April 5, at 6pm local time on Bloomberg International, available in 100+ million homes across Europe. In the exclusive interview, Reaugh provides insight into the company’s technology and market opportunity To view the interview segment, click here. Meten EdtechX Education Group Ltd (NASDAQ:METX) has achieved ‘unicorn’ status as its market cap surpassed US$1bn this week. At close of trading on 31 March, the firm had a market cap of US$1.4bn after its shares ended the session 11.1% higher at US$23.39. The company was formed on 30 March following a merger between EdtechX Holdings, the world's first special purpose acquisition company focused on investing in the education services and education technology industry, and Chinese omnichannel education group Meten.